» Articles » PMID: 24854326

Effects of Professional Oral Health Care on Reducing the Risk of Chemotherapy-induced Oral Mucositis

Overview
Specialties Critical Care
Oncology
Date 2014 May 24
PMID 24854326
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Recent years have seen remarkable progress in cancer therapy, although treatment-induced adverse reactions and complications are not uncommon. Approximately 40 % of patients undergoing chemotherapy for cancer experience adverse reactions in the oral cavity, with nearly half of them developing severe oral mucositis that necessitates postponing therapy and/or changing the drug dosage. The objective of this study was to assess the usefulness of prophylactic professional oral health care (POHC) for preventing mucositis in patients undergoing chemotherapy.

Methods: Twenty-six female patients scheduled for chemotherapy for breast cancer were included in this study and randomized to the self-care or POHC groups. Assessment parameters included oral cavity photographs, plaque control records, Saxon test scores, Oral Assessment Guide scores, and grading using the Common Terminology Criteria for Adverse Events. Beginning before surgery and continuing through the completion of chemotherapy, the POHC patient group received weekly professional oral health care, including scaling, professional cleaning of the tooth surfaces, brushing instructions, and nutritional and lifestyle guidance.

Results: More patients in the self-care group developed oral mucositis than in the POHC group. The Oral Assessment Guide score, which was used as an index of oral mucositis, was also significantly lower in the POHC group. Based on the Oral Assessment Guide and plaque control records, there was almost no deterioration of the oral environment in the POHC group, whereas deterioration was observed in the self-care group.

Conclusions: These findings demonstrate the efficacy of regular POHC in reducing the risk of oral mucositis in breast cancer patients undergoing chemotherapy.

Citing Articles

Efficacy of palifermin in the treatment of oral mucositis in non-hematopoietic stem cell transplant pediatric patients: experience of a single tertiary hospital.

Hamzi H, Binhassan A, Najmeldin A, Alhariri E, Elhussein B, Althibani N J Egypt Natl Canc Inst. 2024; 36(1):38.

PMID: 39617846 DOI: 10.1186/s43046-024-00247-x.


A systematic review of dentists' knowledge, perception, practice and confidence in managing patients with cancers.

Low S, Holden A, Shaw J BMC Health Serv Res. 2024; 24(1):1277.

PMID: 39443974 PMC: 11515570. DOI: 10.1186/s12913-024-11676-8.


Relationship between oral health literacy and oral health-related quality of life in patients with bladder cancer.

Babadi F, Ahmadi A, Sarkarian M, Cheraghi M Front Public Health. 2024; 12:1385443.

PMID: 38846611 PMC: 11155477. DOI: 10.3389/fpubh.2024.1385443.


Oral mucositis & oral health related quality of life in women undergoing chemotherapy for breast cancer in Karachi, Pakistan: A multicenter hospital based cross-sectional study.

Allana A, Shamsi U, Rashid Y, Khan F, Rozi S PLoS One. 2024; 19(4):e0295456.

PMID: 38625907 PMC: 11020356. DOI: 10.1371/journal.pone.0295456.


Human oral mucosa and oral microbiome interactions following supragingival plaque reconstitution in healthy volunteers: a diet-controlled balanced design proof-of-concept model to investigate oral pathologies.

Mougeot J, Beckman M, Morton D, Noll J, Steuerwald N, Brennan M J Oral Microbiol. 2023; 15(1):2246279.

PMID: 37621744 PMC: 10446812. DOI: 10.1080/20002297.2023.2246279.


References
1.
Akintoye S, Brennan M, Graber C, McKinney B, Rams T, Barrett A . A retrospective investigation of advanced periodontal disease as a risk factor for septicemia in hematopoietic stem cell and bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 94(5):581-8. DOI: 10.1067/moe.2002.128960. View

2.
Sonis S . Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998; 34(1):39-43. DOI: 10.1016/s1368-8375(97)00053-5. View

3.
Yoneyama T, Yoshida M, Matsui T, Sasaki H . Oral care and pneumonia. Oral Care Working Group. Lancet. 1999; 354(9177):515. DOI: 10.1016/s0140-6736(05)75550-1. View

4.
Hovan A, Williams P, Stevenson-Moore P, Wahlin Y, Ohrn K, Elting L . A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer. 2010; 18(8):1081-7. DOI: 10.1007/s00520-010-0902-1. View

5.
Raber-Durlacher J, Weijl N, Abu Saris M, de Koning B, Zwinderman A, Osanto S . Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer. 2000; 8(5):366-71. DOI: 10.1007/s005200050004. View